Michael H. Ebert
#125,406
Most Influential Person Now
Michael H. Ebert's AcademicInfluence.com Rankings
Michael H. Ebertchemistry Degrees
Chemistry
#2796
World Rank
#3759
Historical Rank
Analytical Chemistry
#84
World Rank
#90
Historical Rank
Michael H. Ebertbiology Degrees
Biology
#7898
World Rank
#10888
Historical Rank
Histology
#7
World Rank
#18
Historical Rank
Biochemistry
#1108
World Rank
#1225
Historical Rank
Download Badge
Chemistry Biology
Michael H. Ebert's Degrees
- PhD Biochemistry University of California, Berkeley
- Masters Chemistry Stanford University
- Bachelors Chemistry University of California, Berkeley
Why Is Michael H. Ebert Influential?
(Suggest an Edit or Addition)Michael H. Ebert's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. (1981) (2616)
- A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. (1983) (2155)
- Chronic parkinsonism secondary to intravenous injection of meperidine analogues (1979) (1388)
- Aggression, suicide, and serotonin: relationships to CSF amine metabolites. (1982) (941)
- Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. (1986) (411)
- Pharmacologic distinction of different orthostatic hypotension syndromes (1981) (296)
- Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? (1991) (275)
- Abnormalities in CNS monoamine metabolism in anorexia nervosa. (1984) (251)
- Gilles de la tourette syndrome: Clinical and family study of 50 cases (1980) (226)
- The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). (1985) (215)
- Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. (1987) (210)
- A longitudinal study of the effect of different social rearing conditions on cerebrospinal fluid norepinephrine and biogenic amine metabolites in rhesus monkeys. (1989) (204)
- Labile methyl group balances in the human: the role of sarcosine. (1980) (202)
- Memory failures in progressive idiopathic dementia. (1981) (194)
- Huntington's dementia. Clinical and neuropsychological features. (1978) (193)
- A family with histologically confirmed Alzheimer's disease. (1983) (189)
- Conversion of MHPG to vanillylmandelic acid. Implications for the importance of urinary MHPG. (1980) (187)
- Effects of Self-Induced Starvation on Cardiac Size and Function in Anorexia Nervosa (1978) (172)
- Psychological and Behavioral Characteristics of Normal‐Weight Bulimics and Normal‐Weight Controls (1983) (165)
- Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia nervosa. (1983) (165)
- Clinical findings in patients with anorexia nervosa and affective illness in their relatives. (1984) (161)
- Altered gastric emptying and secretion in primary anorexia nervosa. (1979) (153)
- Differences in brain serotonergic metabolism between nonbulimic and bulimic patients with anorexia nervosa. (1984) (152)
- The trial use of clozapine for abnormal involuntary movement disorders. (1979) (151)
- Increased insulin binding to erythrocytes in anorexia nervosa: restoration to normal with refeeding. (1979) (150)
- An outline for the analysis of dementia (1977) (150)
- Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood cerebrospinal fluid barrier for norepinephrine (1977) (142)
- A double-blind controlled trial of lithium carbonate primary anorexia nervosa. (1981) (138)
- Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease. (1979) (136)
- Catecholamine metabolism in primary anorexia nervosa. (1979) (135)
- Cerebrospinal fluid opioid activity in anorexia nervosa. (1982) (131)
- A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa. (1983) (120)
- CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gain (1988) (119)
- The Biochemical Basis of Neuropharmacology, 7th ed (1998) (109)
- Two-dimensional gel electrophoresis of cerebrospinal fluid proteins. (1980) (106)
- d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia. (1982) (104)
- High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides. (1991) (101)
- Cognitive processes in normal and hyperactive children and their response to amphetamine treatment. (1980) (96)
- Strangers in a strange land: a psychobiological study of infant monkeys before and after separation from real or inanimate mothers. (1991) (89)
- Couples group therapy as an adjunct to lithium maintenance of the manic patient. (1977) (89)
- Circadian rhythm in cerebrospinal fluid noradrenaline of man and monkey (1976) (85)
- Modest facilitation on memory in dementia with combined lecithin and anticholinerestase treatment. (1982) (85)
- Deprenyl in Parkinson disease (1981) (85)
- Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and ‘well-state’ bipolar patients (1982) (84)
- Rearing experience and biogenic amine activity in infant rhesus monkeys (1996) (83)
- Prenatal stress alters brain biogenic amine levels in primates (1998) (81)
- Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. (1986) (79)
- Central and peripheral ACTH and cortisol levels in anorexia nervosa and bulimia. (1989) (75)
- Cerebrospinal fluid measures of neurotransmitter changes associated with pharmacological alteration of the despair response to social separation in rhesus monkeys (1984) (70)
- Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa. (1987) (70)
- Vasopressin treatment of cognitive dysfunction in progressive dementia. (1981) (70)
- Caloric intake necessary for weight maintenance in anorexia nervosa: nonbulimics require greater caloric intake than bulimics. (1986) (69)
- Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans. (1999) (65)
- Essential Psychopharmacology: Neuroscientific Basis and Practical Application (1998) (64)
- Altered norepinephrine metabolism following long-term weight recovery in patients with anorexia nervosa (1985) (62)
- Elevated plasma gamma-aminobutyric acid (GABA) levels in individuals with either Prader-Willi syndrome or Angelman syndrome. (1997) (62)
- Studies on the transfer of steroid hormones across the blood-cerebrospinal fluid barrier in the Rhesus Monkey. (1976) (62)
- Effect of physical activity on urinary M.H.P.G. excretion in depressed patients. (1972) (61)
- Disposition and metabolism of MHPG in humans: application to studies in depression. (1984) (57)
- The Behavioral Neurobiology of Self‐injurious Behavior in Rhesus Monkeys (1997) (55)
- The circadian variation of catecholamine metabolism in the subhuman primate (1978) (55)
- Tourette syndrome: clinical and family studies. (1982) (54)
- Lymphocyte proteins in Huntington's disease: quantitative analysis by use of two-dimensional electrophoresis and computerized densitometry. (1982) (52)
- Essential hypertension: central and peripheral norepinephrine. (1981) (52)
- Cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid in adults with attention deficit disorder, residual type (1984) (51)
- Urinary catecholamine metabolites distinguish different types of sympathetic neuronal dysfunction in patients with orthostatic hypotension. (1983) (50)
- Imagery, encoding, and retrieval of information from memory: some specific encoding--retrieval changes in Huntington's disease. (1979) (49)
- Disposition and metabolism of MHPG-CD3 in humans: plasma MHPG as the principal pathway of norepinephrine metabolism and as an important determinant of CSF levels of MHPG. (1984) (49)
- Behavior and motor activity response in hyperactive children and plasma amphetamine levels following a sustained release preparation. (1980) (48)
- Plasma levels of d-amphetamine in hyperactive children (1979) (47)
- Effects of electroconvulsive seizures on amine metabolism in the rat brain. (1973) (45)
- Sleep EEG in Korsakoff's psychosis and Alzheimer's disease (1986) (43)
- Langner's Psychiatric Impairment Scale: a short screening device. (1971) (43)
- Decreased caloric intake in normal-weight patients with bulimia: comparison with female volunteers. (1989) (42)
- Histologic changes in sensory nerves of the skin in herpes zoster. (1949) (42)
- URINARY CATECHOLAMINES AND AMPHETAMINE EXCRETION IN HYPERACTIVE AND NORMAL BOYS (1978) (41)
- Intellect, perceptual characteristics, and weight gain in anorexia nervosa. (1983) (40)
- Evaluation of 5‐[18F]Fluoropropylepidepride as a potential pet radioligand for imaging dopamine D2 receptors (1993) (40)
- Behavioral effects of carbidopa/levodopa in hyperactive boys. (1982) (40)
- Contribution of CNS neuropeptide (NPY, CRH, and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa. (1989) (40)
- Current diagnosis & treatment psychiatry (2000) (39)
- The hyperactive child syndrome: Peripheral sympathetic nervous system function and the effect of d-amphetamine (1981) (39)
- High affinity dopamine D2 receptor radioligands. 3. [123I] and [125I]epidepride: in vivo studies in rhesus monkey brain and comparison with in vitro pharmacokinetics in rat brain. (1993) (39)
- Contribution of plasma homovanillic acid (HVA) to urine and cerebrospinal fluid HVA in the monkey and its pharmacokinetic disposition. (1978) (39)
- Language and speech abnormalities in Tourette syndrome. (1982) (39)
- Effects of clonidine on central and peripheral catecholamine metabolism (1984) (38)
- The adrenal medullary response to hypoglycemia in patients with orthostatic hypotension. (1980) (38)
- Trial of chlorimipramine and desipramine for gilles de la tourette syndrome (1979) (37)
- Amphetamine-induced catecholamine activation in schizophrenia and depression: behavioral and physiological effects. (1977) (37)
- Sleep in Gilles de la Tourette syndrome. (1980) (36)
- Current Diagnosis and Treatment in Psychiatry (2000) (36)
- Gilles de la Tourette's syndrome, tardive dyskinesia, and psychosis in an adolescent. (1978) (34)
- Uncoupling of serotonergic and noradrenergic systems in depression: Preliminary evidence from continuous cerebrospinal fluid sampling (1997) (34)
- Caloric consumption and activity levels after weight recovery in anorexia nervosa: A prolonged delay in normalization (1986) (34)
- Cerebrospinal Fluid Amine Metabolites and the Probenecid Test (1980) (33)
- Disturbances of noradrenergic systems in normal weight bulimia: Relationship to diet and menses (1990) (33)
- Biogenic amine activity in response to fluoxetine and desipramine in differentially reared rhesus monkeys (1999) (32)
- Qualitative and quantitative high performance liquid chromatographic analysis of monoamine neurotransmitters and metabolites in cerebrospinal fluid and brain tissue using reductive electrochemical detection. (1990) (32)
- Association of a Critical CSF Tryptophan Threshold Level with Depressive Relapse (2003) (32)
- Central nervous system catecholamine metabolism in Korsakoff's psychosis (1984) (31)
- Norepinephrine in Cerebrospinal Fluid Basic Studies, Effects of Drugs and Disease (1980) (31)
- Cholinergic treatment in the Tourette syndrome. (1980) (31)
- Hypersensitivity to d-amphetamine several years after early social deprivation in rhesus monkeys (2004) (31)
- Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: serial sampling studies. (1994) (30)
- Protein variations associated with Lesch-Nyhan syndrome. (1981) (30)
- Relationship Between Resident-In-Training Examination in Psychiatry and Subsequent Certification Examination Performances (2009) (28)
- A comparative analysis of primary anorexics and schizophrenics on the MMPI. (1981) (28)
- Alpha‐adrenergic receptors in orthostatic hypotension syndromes (1984) (27)
- Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate (1978) (27)
- Lithium in Mania: Clinical Trials and Controlled Studies (1973) (26)
- Regional cerebral glucose metabolism in patients with alcoholic Korsakoff's syndrome (1985) (26)
- Urinary 3-methyoxy-4-hydroxyphenylglycol and homovanillic acid response to d-amphetamine in hyperactive children. (1981) (26)
- Decreased 6‐hydroxymelatonin excretion in Korsakoff's psychosis (1984) (25)
- Memory-learning impairments in progressive dementia and depression. (1982) (24)
- Serial cerebrospinal fluid tryptophan and 5-hydroxy indoleacetic acid concentrations in healthy human subjects. (2002) (23)
- Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT3 receptor antagonist, in the mouse elevated plus-maze (2001) (23)
- Hyperkinetic syndrome and Tourette syndrome. (1982) (23)
- Provocative drug testing in Tourette's syndrome: d- and l-amphetamine and haloperidol. (1984) (22)
- Urinary catecholamine metabolites and effects of clonidine in patients with alcohol amnestic disorder (1983) (22)
- Kinetics of Homovanillie Acid and Determination of Its Production Rate in Humans (1982) (22)
- Neuroendocrine function in Huntington's disease: dopaminergic regulation of prolactin release. (1978) (22)
- Amphetamine challenge: effects in previously isolated rhesus monkeys and implications for animal models of schizophrenia. (1983) (21)
- Heterogeneity and variability in Tourette syndrome. (1982) (20)
- From too little too late to early and often: child psychiatry education during medical school (and before and after). (2007) (20)
- Characterization of Desamino-5-[125I]Iodo-3-Methoxy-Zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain (1998) (19)
- Intravenous probenecid loading (1976) (18)
- Distribution of free and conjugated dopamine in monkey brain, peripheral tissues and cerebrospinal fluid determined by high-performance liquid chromatography (1983) (17)
- Neurotransmitter Metabolism in Anorexia Nervosa (1984) (17)
- Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors. (1999) (17)
- Cerebrospinal fluid probenecid studies: a reinterpretation. (1983) (17)
- A PSORIASIFORM ERUPTION WITH PUSTULAR EXACERBATIONS (1933) (17)
- Daily fluctuation in the concentration on cAMP in the conscious primate brain (1977) (16)
- MULTIPLE PIGMENTED NEVI: A STUDY OF THE ORIGIN OF THE NEVUS CELL (1938) (16)
- Disturbances of norepinephrine metabolism and alpha-2 adrenergic receptor activity in anorexia nervosa: relationship to nutritional state. (1985) (16)
- Hormonal responses to hypoglycemia in orthostatic hypotension patients with adrenergic insufficiency. (1981) (15)
- METABOLISM AND TURNOVER OF MHPG IN THE MONKEY (1979) (15)
- Demonstration of Conjugated Dopamine in Monkey CSF by Gas Chromatography‐Mass Spectrometry (1982) (14)
- Probenecid-induced norepinephrine elevations in plasma and CSF. (1978) (13)
- Kinetics of homovanillic acid and determination of its production rate in the rhesus monkey. (1979) (13)
- Effect of moderate exercise on urinary MHPG in depressed patients. (1979) (13)
- ACTIONS OF BROMOCRIPTINE IN THE SHY – DRAGER AND STEELE – RICHARDSON – OLSZEWSKI SYNDROMES (1979) (12)
- Norepinephrine elevations in cerebrospinal fluid after d- and l-amphetamine. (1979) (12)
- Plasma d-amphetamine absorption and elimination in hyperactive children. (1978) (12)
- Central noradrenergic adaptation to long-term treatment with imipramine in rhesus monkeys (1980) (11)
- Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures (2005) (11)
- Isoproterenol infusion test in anorexia nervosa: assessment of pre- and post-beta-noradrenergic receptor activity. (1990) (11)
- Labeling of (S)‐DES‐4‐amino‐3‐[125I]iodozacopride (DAIZAC), a high‐affinity radioligand for the 5‐HT‐3 receptor (1996) (11)
- Pilot Trial of Mianserin Hydrochloride for Childhood Hyperactivity (1984) (11)
- [125I]iodopride: a specific high affinity radioligand for labelling striatal dopamine D-2 receptors. (1988) (11)
- A comparison of anorexics and schizophrenics on psychodiagnostic measures (1982) (11)
- Extracellular Cyclic Nucleotide Metabolism in the Human Central Nervous System (1980) (10)
- Comparison of radioimmunoassay and gas chromatographic mass spectrometric assay for d-amphetamine. (1979) (10)
- Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-maze. (2001) (9)
- VIRUS DISEASES OF SKIN, WITH SPECIAL REFERENCE TO ELEMENTARY AND INCLUSION BODIES: I. VARIOLA-VACCINIA AND MOLLUSCUM CONTAGIOSUM (1943) (9)
- Separation Models and Depression (1983) (9)
- Dissociation between central and peripheral noradrenergic activity in essential hypertension. (1980) (9)
- Effect of bethanechol on gastric functions in primary anorexia nervosa (1981) (8)
- Synthesis and 5-HT-3 receptor binding activity of 5-[125I]iodo-2,3-dimethoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide and its 5-halogen-2-alkoxyl homologues (1997) (7)
- Cerebrospinal fluid norepinephrine concentrations and dynamics in depressed patients and normal volunteers (1993) (7)
- Studies on the transfer of steroid hormones across the blood-cerebrospinal fluid barrier in the rhesus monkey. II. (1977) (6)
- Behavioral and Psychopharmacologic Pain Management: Contents (2010) (6)
- Effects of alcohol on cerebrospinal fluid norepinephrine in rhesus monkeys (2004) (6)
- Serum dopamine-beta-hydroxylase in depressed patients and the effect of electroconvulsive shock treatment (2004) (6)
- Catecholamine metabolism during clonidine withdrawal (2004) (6)
- Tuberculosis cutis? Sarcoid? (1951) (6)
- Fasting and postprandial cerebrospinal fluid glucose concentrations in healthy women and in an obese binge eater. (1995) (5)
- Differential labelling of origins of urinary catecholamine metabolites by dopamine-C14. (1975) (5)
- Hypoxanthine guanine phosphoribosyl‐transferase (HGPRT) (1979) (5)
- Drug Interactions in Psychiatry, 2nd ed (1998) (5)
- REGIONAL CEREBRAL GLUCOSE USE IN PATIENTS WITH ALCOHOLIC KORSAKOFF'S SYNDROME.: V (1984) (5)
- Questioning a dopaminergic hypothesis. (1981) (4)
- Maintenance of certification in psychiatry. (2009) (4)
- Core Competencies for Psychiatric Education : Defining , Teaching , and Assessing Resident Competence (2005) (4)
- A Double‐Blind Trial of Δ9-Tetrahydrocannabinol in Primary Anorexia Nervosa (1983) (4)
- Sleep EEG in Korsakoffʼs psychosis and Alzheimerʼs disease (1987) (3)
- Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinity. (1997) (3)
- The effects of the Affordable Care Act on the practice of psychiatry. (2013) (3)
- Cardiovascular effects of psychotropic drugs. (1969) (3)
- (S)-4-amino-5-chloro-3-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide (TRIZAC), a high-affinity ligand for the 5-HT-3 receptor (1996) (3)
- The herpes problem. (1949) (3)
- The Effects of Disulfiram on Peripheral and Central Norepinephrine Metabolism and Blood Pressure (1980) (3)
- CHOLINERGIC REM SLEEP INDUCTION—A TRAIT MARKER OF AFFECTIVE ILLNESS? (1982) (3)
- I-125-LIZAC, a novel ligand binding with high affinity to 5-HT-3 CNS receptors (1995) (3)
- Behavioral Neurology: Practical Science of Mind and Brain, 2nd ed (2004) (2)
- Neural leprosy. (1948) (2)
- Psychopharmacologic and psychotherapeutic approaches to pain management (2010) (2)
- Psychological and Psychosocial Evaluation of the Chronic Pain Patient (2011) (2)
- (S)-4-Amino-5-chloro-3-iodo-2-methoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamide (TRIZAC), a High-Affinity Ligand for the 5-HT-3 Receptor. (1997) (2)
- Boeck's sarcoid. (1948) (2)
- THE USE OF COLLOIDAL CALOMEL OINTMENT IN DERMATOLOGY (1939) (2)
- Dr. Kaye and Associates Reply (1983) (2)
- Synthesis and 5-HT-3 receptor binding of 2- and 3-(halo)alkoxyl substituted (S)-N-(1-azabicyclo[2.2.2]oct-3-yl)-5-chlorobenzamides as potential radioligands. (1998) (2)
- Hypoxanthine guanine phosphoribosyltransferase (HGPRT) in Gilles de la Tourette syndrome. (1979) (2)
- Catecholamine Metabolism in Hyperactive Children (1985) (2)
- Sarcoidosis with uveitis. (1951) (2)
- Clinical research in neuropsychiatry. (1983) (2)
- Pityriasis rubra pilaris with exfoliation. (1947) (1)
- Lack of effect of chronic developmental lead treatment on biogenic amines and metabolites in monkey cerebrospinal fluid. (1993) (1)
- Synthesis and 5‐HT‐3 Receptor Binding Activity of 5‐(125I)Iodo‐2,3‐ dimethoxy‐N‐(1‐azabicyclo(2.2.2)oct‐3‐yl)benzamide and Its 5‐Halogen‐2‐ alkoxyl Homologues. (1997) (1)
- Gastric Function in Primary Anorexia Nervosa (1984) (1)
- Application of Immunoassay Techniques in Psychopharmacology (1988) (1)
- Behavioral and neurochemical effects of electroconvulsive shock in the withdrawal syndrome of morphine dependent rats. (1981) (1)
- FINITELY PRESENTABLE MORPHISMS IN EXACT SEQUENCES (2010) (1)
- Vitamins in Dermatology (1942) (1)
- Catecholamine Metabolism in Anorexia Nervosa (1985) (1)
- TREATMENT OF PITYRIASIS ROSEA BY THE INJECTION OF TYPHOID VACCINE (1943) (1)
- Treatment of herpes zoster. (1951) (0)
- Behavioral Sciences: PreTest Self-Assessment and Review (2001) (0)
- Measurement of tetra hydro biopterin in human cerebro spinal fluid (1979) (0)
- Maintenance of certification in psychiatry. (2009) (0)
- A case for diagnosis (lymphoblastoma?). (1946) (0)
- Comprar Behavioral and Psychopharmacological Pain Management | Michael H. Ebert | 9780521884341 | Cambridge University Press (2010) (0)
- Behavioral and Psychopharmacologic Pain Management: Introduction (2010) (0)
- Disseminated lupus erythematosus. (1948) (0)
- Comprar Current Diagnosis And Treatment Psychiatry 3rd Ed. | Michael Ebert | 9780071754422 | MCGRAW HILL (2016) (0)
- The Kazdin Method for Parenting the Defiant Child : With No Pill , No Therapy , No Contest of Wills (2009) (0)
- A case for diagnosis (pemphigus?). (1947) (0)
- Caloric Consumption and Activity Levels After Weight Recovery in Anorexia Nervosa: Normalization , A Prolonged Delay in (1986) (0)
- Two-Dimensional Gel Electrophoresisof CerebrospinalFluidProteins ’ David Goldman (2004) (0)
- [Not Available]. (1947) (0)
- Chronic myelogenous leukemia with purpura. (1948) (0)
- A case for diagnosis (squamous cell epithelioma?). (1946) (0)
- A case for diagnosis: lichen planus? pemphigus? (1950) (0)
- The Affordable Care Act and Practice in Psychiatry (2013) (0)
- USE OF DEUTERIUM-LABELLED METHIONINE AND HVA TO STUDY DOPAMINE METABOLISM IN VIVO (1979) (0)
- Porphyria with bullous lesions. (1952) (0)
- Urticaria pigmentosa of 15 years' duration in a woman aged 41. (1950) (0)
- Seborrheic dermatitis with a decided palpebral involvement. (1946) (0)
- 291. Uncoupling of CNS serotonin and norepinephrine systems in depression (1996) (0)
- Reply (1984) (0)
- Disturbances in Brain Neurotransmitter Systems in Anorexia Nervosa: A Review of CSF Studies (2013) (0)
- Behavioral and Psychopharmacologic Pain Management: Realizing the promise of optimal pain care: What does the future hold? (2010) (0)
- Ethical Issues in Forensic Psychiatry: Minimizing Harm (2012) (0)
- Attention-Deficit Hyperactivity Disorder : A Handbook for Diagnosis and Treatment (2008) (0)
- Developmental Disabilities From Childhood to Adulthood: What Works for Psychiatrists in Community and Institutional Settings (2012) (0)
- Favus in an American-born family. (1946) (0)
- Leprosy, mixed type. (1948) (0)
- CHICAGO DERMATOLOGICAL SOCIETY (1944) (0)
- MOLECULAR PROBES FOR HUMAN GENETIC DISEASES BY TWO-DIMENSIONAL PROTEIN ELECTROPHORESIS AND SILVER STAINING (1983) (0)
- A COMPARATIVE STUDY OF THE HERROLD PRECIPITATION TEST AND THE WASSERMANN REACTION (1924) (0)
- The Mindful Brain : Reflection and Attunement in the Cultivation of Well-Being (2009) (0)
- Dr. van Kammen and Associates Reply (1983) (0)
- Maintenance of Certification in Psychiatry: (commentary) (2009) (0)
- Herpes Zoster (1941) (0)
- Excitotoxins and the NMDA-receptor exciting times for neuroscience research. (1988) (0)
- Sickle cell ulcers treated with red blood cells. (1946) (0)
- Depression and cancer. (1997) (0)
- Acrokeratosis verruciformis (Hopf). (1948) (0)
- Psychotherapy Supervision and Consultation in Clinical Practice (2007) (0)
- Synthesis and Radiolabeling of (S)-4-Amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the Active Enantiomer of [125I]Iodozacopride, and Reevaluation of Its 5-HT3 Receptor Affinity. (1998) (0)
- Generalized progressive scleroderma. (1948) (0)
- QUANTITATIVE TWO-DIMENSIONAL ELECTROPHORESIS AS A SCREEN FOR GENETIC DISEASE MARKERS (1981) (0)
- Subacute disseminated lupus erythematosus. (1948) (0)
- Cognitive Therapy of Schizophrenia (1976) (0)
- Subject Index Vol. 60, 1994 (1994) (0)
This paper list is powered by the following services:
